SCHEMBL1633698

SCHEMBL1633698

C#Cc1cc(OC2CCCNCC2)c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 11/20 0.48
CCND1 P24385 10/20 0.48
CDK1 P06493 8/20 0.48
CCNB1 P14635 8/20 0.48
CCNE1 P24864 8/20 0.48
CDK2 P24941 8/20 0.48
JAK2 O60674 4/20 0.48
TBK1 Q9UHD2 3/20 0.48
LRRK2 Q5S007 2/20 0.46
SYK P43405 3/20 0.45
CCND2 P30279 3/20 0.44
CCND3 P30281 3/20 0.44
CCNB2 O95067 2/20 0.44
CCNB3 Q8WWL7 2/20 0.44
CCNE2 O96020 2/20 0.44
CCNA2 P20248 2/20 0.44
CCNA1 P78396 2/20 0.44
JAK1 P23458 1/20 0.44
TYK2 P29597 1/20 0.44
JAK3 P52333 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632749 0.97 JAK2 (0.50) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL1635198 0.89 TBK1 (0.56) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL1634852 0.88 CDK4 (0.48) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL14258585 0.88 CDK4 (0.52) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL1633275 0.85 CDK4 (0.50) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL1633593 0.84 MAPK10 (0.46) CDK4CCND1CDK1CCNE1CDK2
SCHEMBL13498239 0.84 CDK4 (0.51) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL13498240 0.84 CDK4 (0.53) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL12725100 0.83 CDK4 (0.52) CDK4CCND1CDK1CCNB1CCNE1
SCHEMBL1632752 0.83 SYK (0.45) CDK4CCND1CDK1CCNB1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
WO-2007117607-A2 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2007-10-18 WO disclosed